Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LIVN · against 241 other Healthcare companies of similar size
Ranked #157 of 242 · scores higher than 35% of peers · safety percentile 39
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)26 peers with a safety percentile of 30–39, including LIVN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | LIVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 236 reported | 0.27× | 0.26× | 49% | 33% | |
| BetaLower is better · 239 reported | 0.87 | 0.55 | 29% | 33% | |
| Current ratioHigher is better · 234 reported | 1.45× | 2.52× | 21% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 2.2B USD | 99 | 48 | |
| 153 | 8.5B USD | 40 | 28 | |
| 154 | 47.8B HKD (≈$6.1B) | 40 | 58 | |
| 155 | 21.5B DKK (≈$3.2B) | 40 | 58 | |
| 156 | 4.3B USD | 40 | 54 | |
| 157 | 4.4B USD | 39 | 66 | |
| 158 | 4.1B USD | 38 | 39 | |
| 159 | 10.8B SAR (≈$2.9B) | 38 | 68 | |
| 160 | 19.0B CNY (≈$2.7B) | 38 | 55 | |
| 161 | 7.4B USD | 37 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score